Cargando…
Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors
Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763839/ https://www.ncbi.nlm.nih.gov/pubmed/33322488 http://dx.doi.org/10.3390/pharmaceutics12121205 |
_version_ | 1783628113620500480 |
---|---|
author | Griffith, Jessica I. Rathi, Sneha Zhang, Wenqiu Zhang, Wenjuan Drewes, Lester R. Sarkaria, Jann N. Elmquist, William F. |
author_facet | Griffith, Jessica I. Rathi, Sneha Zhang, Wenqiu Zhang, Wenjuan Drewes, Lester R. Sarkaria, Jann N. Elmquist, William F. |
author_sort | Griffith, Jessica I. |
collection | PubMed |
description | Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what is referred to as the blood–tumor barrier (BTB). Herein, we discuss this heterogeneity, how it contributes to the failure of novel pharmaceutical treatment strategies, and why a “whole brain” approach to the treatment of brain tumors might be beneficial. We discuss various methods by which these obstacles might be overcome and assess how these strategies are progressing in the clinic. We believe that by approaching brain tumor treatment from this perspective, a new paradigm for drug delivery to brain tumors might be established. |
format | Online Article Text |
id | pubmed-7763839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77638392020-12-27 Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors Griffith, Jessica I. Rathi, Sneha Zhang, Wenqiu Zhang, Wenjuan Drewes, Lester R. Sarkaria, Jann N. Elmquist, William F. Pharmaceutics Review Effective treatments for brain tumors remain one of the most urgent and unmet needs in modern oncology. This is due not only to the presence of the neurovascular unit/blood–brain barrier (NVU/BBB) but also to the heterogeneity of barrier alteration in the case of brain tumors, which results in what is referred to as the blood–tumor barrier (BTB). Herein, we discuss this heterogeneity, how it contributes to the failure of novel pharmaceutical treatment strategies, and why a “whole brain” approach to the treatment of brain tumors might be beneficial. We discuss various methods by which these obstacles might be overcome and assess how these strategies are progressing in the clinic. We believe that by approaching brain tumor treatment from this perspective, a new paradigm for drug delivery to brain tumors might be established. MDPI 2020-12-11 /pmc/articles/PMC7763839/ /pubmed/33322488 http://dx.doi.org/10.3390/pharmaceutics12121205 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Griffith, Jessica I. Rathi, Sneha Zhang, Wenqiu Zhang, Wenjuan Drewes, Lester R. Sarkaria, Jann N. Elmquist, William F. Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title | Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title_full | Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title_fullStr | Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title_full_unstemmed | Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title_short | Addressing BBB Heterogeneity: A New Paradigm for Drug Delivery to Brain Tumors |
title_sort | addressing bbb heterogeneity: a new paradigm for drug delivery to brain tumors |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763839/ https://www.ncbi.nlm.nih.gov/pubmed/33322488 http://dx.doi.org/10.3390/pharmaceutics12121205 |
work_keys_str_mv | AT griffithjessicai addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT rathisneha addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT zhangwenqiu addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT zhangwenjuan addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT dreweslesterr addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT sarkariajannn addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors AT elmquistwilliamf addressingbbbheterogeneityanewparadigmfordrugdeliverytobraintumors |